It has previously been suggested that an ester derivative of 3BP, 3-bromopyruvate propyl ester, exhibits a more potent inhibitory effect on GAPDH than on HKII in CRC cells HCT116 and HT29 [57]. Here, GAPDH is linked to colorectal carcinoma.